Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion

References

• Wood B, Molecular Higgs D. Basis of thalassemia syndromes. In: Beaumont C, Beris P, Beauzard Y, Brugnara C, editors. Disorders of Erythropoiesis, Erythrocytes, and Iron Metabolism. Italy: European School of Hematology; 2009:251–262.
   Google Scholar
• Taher AT, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Guidelines for the management of non-transfusion dependent thalassemia (NTDT). In: Thalassemia International Federation. Cyprus: Publisher Thalassemia International Federation; 2013:1–8.
   Google Scholar
• Musallam KM, Rivella S, Vichinsky E, Rachmilewtz EA. Review articles. Non-transfusion dependent thalassemias. Hematol J. 2013;98(6):833–844. doi:10.3324/haematol.2012.066845
   Google Scholar
• Hematology Oncology Indonesia Working Group. Data Registri Thalassemia Indonesia. Children Thalassemia Center RSUPNCM Jakarta; 2016.
   Google Scholar
• Viprakasit V, Porter J. Iron overload and chelation. In: Capellini M, Cohen A, Porter J, Taher A, Viprakasit V, editors. Guidelines for the Management of Transfusion-Dependent Thalassemia (TDT). 3rd ed. Thalassemia International Federation: Thalassemia International Federation Publishers; 2014:42–96. TIF Publication No. 20.
   Google Scholar
• Taher AT, Musallam KM, Beshlawy A, et al. Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. Br J Haematol. 2010;150(4):480–497. doi:10.1111/j.1365-2141.2010.08218.x
   PubMed Web of Science ®Google Scholar
• Musallam KM, Cappellini MD, Wood JC, et al. Elevated liver iron concentration is a marker of increased morbidity in patients with β-thalassemia intermedia. Hematol J. 2011;96(11):1605–1612. doi:10.3324/haematol.2011.047852
   Google Scholar
• Musallam KM, Cappellini MD, Taher AT. Evaluation of the 5 mg/g liver iron concentration threshold and its association with morbidity in patients with β- thalassemia intermedia. Blood Cells Mol Dis. 2013;51(1):35–38. doi:10.1016/j.bcmd.2013.01.015
   PubMed Web of Science ®Google Scholar
• Pantalone GR, Lace D, Valenza F, et al. Hepatocellular carcinoma in patients with thalassemia syndrome: clinical characteristics and outcome in a long-term single center experience. Br J Haematol. 2010;150(2):226–248. doi:10.1111/j.1365-2141.2010.08179.x
   Web of Science ®Google Scholar
• Taher AT, Viprakasit V, Musallam KM, Cappellini MD. Critical review: treating iron overload in patients with non-transfusion-dependent thalassemia. Am J Hematol. 2013;88(5):409–415. doi:10.1002/ajh.23405
   PubMed Web of Science ®Google Scholar
• Taher AT, Musallam KM, Wood JC, Cappellini MD. Magnetic resonance evaluation of hepatic and myocardial iron deposition in thalassemia intermedia independent transfusion – compared to regularly transfused thalassemia major patients. Am J Hematol. 2010;85(4):288–290. doi:10.1002/ajh.21626
   PubMed Web of Science ®Google Scholar
• Puliyel M, Sposto R, Bardoukas V, et al. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Am J Hematol. 2014;89(4):391–394. doi:10.1002/ajh.23650
   PubMed Web of Science ®Google Scholar
• Pipaliya N, Solanke D, Parikh P, et al. Comparison of tissue elastography with magnetic resonance imaging T2 * and serum ferritin quantification in detecting liver iron overload in the patient with thalassemia major. Clin Gastroenterol Hepatol. 2016.
   Web of Science ®Google Scholar
• Musallam KM, Motta I, Salvatori M, et al. Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness transfusion-independent in patients with β-thalassemia intermedia. Blood Cells Mol Dis. 2012;49(3–4):136–139. doi:10.1016/j.bcmd.2012.06.001
   PubMed Web of Science ®Google Scholar
• Fraquelli M, Cassinerio E, Roghi A, et al. Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol. 2010;85(8):564–568. doi:10.1002/ajh.21752
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev. 2012;26S:S3–6. doi:10.1016/S0268-960X(12)70003-6
   Web of Science ®Google Scholar
• Sengsuk C, Tangvarasittichai O, Chantanaskulwong P, et al. Association of iron overload with oxidative stress, hepatic damage, and dyslipidemia in transfusion-dependent β-thalassemia/HbE patients. Ind J Clin Biochem. 2014;29(3):298. doi:10.1007/s12291-013-0376-2
   Google Scholar
• Viprakasit V, Tyan P, Rodmai S, Taher AT. Review. Identification and key management of non-transfusion-dependent thalassemia patients: not a rare but under-recognized potentially condition. Orphanet J Rare Dis. 2014;9(131):1–11. doi:10.1186/s13023-014-0131-7
   Web of Science ®Google Scholar
• Cappellini MD, Musallam KM, Cesarwtti C, Taher A. Thalassemia intermedia. In: Beaumont C, Beris P, Beauzard Y, Brugnara C, editors. Disorders of Erythropoiesis, Erythrocytes, and Iron Metabolism. Italy: European School of Hematology; 2009:287.
   Google Scholar
• Maharani EA, Soedarmono Y, Nainggolan IM. Frequency of thalassemia carrier and Hb variant and the quality of stored donor blood. Med J Indones. 2014;23(4):209–212. doi:10.13181/mji.v23i4.766
   Google Scholar
• Musallam KM, Cappellini MD, Wood JC, Taher AT. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev. 2012;26S:S16–9. doi:10.1016/S0268-960X(12)70006-1
   Web of Science ®Google Scholar
• Musallam KM, Taher AT, Rachmilewitz EA. Β-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012;2(7):1–15. doi:10.1101/cshperspect.a013482
   Web of Science ®Google Scholar
• Taher AT, Musallam KM, Cappellini MD, Weatherall DJ. Optimal management of β thalassemia intermedia. Br J Haematol. 2011;152(5):512–523. doi:10.1111/j.1365-2141.2010.08486.x
   PubMed Web of Science ®Google Scholar
• Taher A, Isma’eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006;37(1):12–20. doi:10.1016/j.bcmd.2006.04.005
   PubMed Web of Science ®Google Scholar
• Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body of iron metabolism and the pathophysiology of iron overload. Int J Haematol. 2008;88(1):7–15. doi:10.1007/s12185-008-0120-5
   PubMed Web of Science ®Google Scholar
• Rivella S. The role of ineffective erythropoiesis in a non-transfusion-dependent thalassemia. Blood Rev. 2012;26S:S12–5. doi:10.1016/S0268-960X(12)70005-X
   Web of Science ®Google Scholar
• Batts KP. Iron overload syndromes and the liver. Mod Pathol. 2007;20(S1):S31–9. doi:10.1038/modpathol.3800715
   Web of Science ®Google Scholar
• Taher A, Hershko C, Cappellini MD. Iron overload in thalassemia intermedia: reassessment of iron chelation strategies. Br J Haematol. 2009;147(5):634–640. doi:10.1111/j.1365-2141.2009.07848.x
   PubMed Web of Science ®Google Scholar
• Musallam KM, Cappellini MD, Daar S, et al. Serum ferritin levels and morbidity risk in transfusion-independent in patients with β-thalassemia intermedia: the ORIENT Study. Hematol J. 2014;99(11):e218–21. doi:10.3324/haematol.2013.097220
   Google Scholar
• Musallam KM, Cappellini MD, Daar S, Karimi M, El-Beshlawy A, Taher AT. Serum ferritin levels and morbidity in β-thalassemia intermedia: a 10-year cohort study. [Abstract]. Am Soc Hematol. 2012.
   Google Scholar
• Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann NY Acad Sci. 2010;1202(1):1–9. doi:10.1111/j.1749-6632.2010.05544.x
   Web of Science ®Google Scholar
• Pietrangelo A. Mechanism of iron hepatotoxicity. Hepatol. 2016;65(1):226–227. doi:10.1016/j.jhep.2016.01.037
   Google Scholar
• Britton RS, Leicester KL, Bacon BR. Iron toxicity and chelation therapy. Int J Haematol. 2002;76(3):219–228. doi:10.1007/BF02982791
   PubMed Web of Science ®Google Scholar
• Taher A, Rassi F, Isma’eel H, Koussa S, Inati A, Cappellini MS. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia. Hematol J. 2008;93(10):1584–1586. doi:10.3324/haematol.13098
   Google Scholar
• Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E. Serum ferritin underestimates liver iron concentration in patients with thalassemia transfusion independent as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007;49(3):329–332. doi:10.1002/pbc.21275
   PubMed Web of Science ®Google Scholar
• Shah R, Treban A, Das R, Marwaha R. Serum ferritin in thalassemia intermedia. Indian J Hematol Blood Transfus. 2014;30(4):281–285. doi:10.1007/s12288-013-0267-y
   PubMed Web of Science ®Google Scholar
• Taher AT, Porter JB, Kattamis A, et al. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia. Br J Haematol. 2015;168(2):284–290. doi:10.1111/bjh.13119
   PubMed Web of Science ®Google Scholar
• Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill US. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American association for the study of liver disease. Hepatology. 2011;54(1):328–343. doi:10.1002/hep.24330
   Web of Science ®Google Scholar
• Garbowski M, Carpenter J, Smith G, et al. Biopsy-based calibration of T2 * magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferris can. J Cardiovasc Magn Reson. 2014;16(40):1–11. doi:10.1186/1532-429X-16-40
   Web of Science ®Google Scholar
• Szurowska E, Sikorska K, Swieszewska E, et al. The role of MR imaging in the detection of hepatic iron overload in patients with cirrhosis of different origins. BMC Gastroenterol. 2010;10(13):1–14.
   Google Scholar
• Timothy G, Pierre CP, Chua-anusom W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105(2):855–856. doi:10.1182/blood-2004-01-0177
   Web of Science ®Google Scholar
• Echeverria J, Castiella A, Emparanza J. Quantification of iron concentration in the liver by MRI. Insights Imaging. 2012;3(2):173–180. doi:10.1007/s13244-011-0132-1
   Google Scholar
• Henninger B, Kremser C, Rauch S, et al. Evaluation of MR imaging with T1 and T2 * mapping for the determination of hepatic iron overload. Eur Radiol. 2012;22(11):2478–2486. doi:10.1007/s00330-012-2506-2
   PubMed Web of Science ®Google Scholar
• Gandon Y, Oiivie D, Guyader D, Aube C, Oberti F, Sebille V. Non-invasive assessment of hepatic iron stores by MRI. Lancet North Am. 2004;363(9406):357–362. doi:10.1016/S0140-6736(04)15436-6
   PubMed Web of Science ®Google Scholar
• Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2 * mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease Patients. Blood. 2005;106(4):1460–1465. doi:10.1182/blood-2004-10-3982
   PubMed Web of Science ®Google Scholar
• Sarigianni M, Liakos A, Vlachaki E, et al. Accuracy of magnetic resonance imaging in the diagnosis of liver iron overload: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(1):55–63. doi:10.1016/j.cgh.2014.05.027
   PubMed Web of Science ®Google Scholar
• Angelucci E, Giovagnoni A, Valeri G, et al. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood. 1997;90(12):4736–4742. doi:10.1182/blood.V90.12.4736
   Web of Science ®Google Scholar
• Verissimo MP, Loggetto SR, Fabron A Jr., et al. Special articles Brazilian protocol for thalassemia association of iron chelation therapy in patient under regular transfusion. Reu Braz Hematol. 2013;35(6):428–434.
   PubMedGoogle Scholar
• Castiella A, Zapata E. Non-invasive prediction methods for liver fibrosis in hemochromatosis: one step beyond. World J Hepatol. 2010;2(7):251–255. doi:10.4254/wjh.v2.i7.251
   Google Scholar
• Papastertergiou V, Tsochatzis E, Burroughts AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol. 2012;25(3):218–231.
   Google Scholar
• Adhoute X, Foucher J, Laharie D, et al. Diagnosis of liver fibrosis and other FibroScan using noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol. 2008;32(2):180–187. doi:10.1016/j.gcb.2007.12.021
   PubMedGoogle Scholar
• Talwalkar J, Kurtz D, Schoenleber S, West C, Montori V. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10):1214–1220. doi:10.1016/j.cgh.2007.07.020
   PubMed Web of Science ®Google Scholar
• Paparo F, Cevasco L, Zefiro D, et al. Diagnostic value of real-time elastography in the assessment of hepatic fibrosis in patients with liver iron overload. Eur J Radiol. 2013;82(12):e755–61. doi:10.1016/j.ejrad.2013.08.038
   PubMed Web of Science ®Google Scholar
• Marco V, Bronte F, Cabibi D, et al. Noninvasive assessment of liver fibrosis in thalassemia major patients by transient elastography (TE) – lack of interference by iron deposition. Br J Haematol. 2009;148(3):476–479. doi:10.1111/j.1365-2141.2009.07996.x
   Web of Science ®Google Scholar
• Taher AT, Cappellini MD, Musallam KM. Recent advances and treatment challenges in patients with non-transfusion-dependent thalassemia. Blood Rev. 2012;26S:S1–2. doi:10.1016/S0268-960X(12)00028-8
   Web of Science ®Google Scholar
• Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long term monitoring of serum ferritin to predict complication of iron overload in thalassemia major. Br J Haematol. 2000;110(4):971–977. doi:10.1046/j.1365-2141.2000.02298.x
   PubMed Web of Science ®Google Scholar
• Children Thalassemia Center RSUPNCM. Data MRI T2 * liver and heart in Dept. pediatrics 2014 Jakarta. Anak: Thalassemia Center; 2014
   Google Scholar
• Olivieri NF, Gary MB, Doreen M, Matitiahu B, Laurence MB. Iron-chelation therapy with oral deferiprone in patients with major thalassemia. N Engl J Med. 1995;332(14):918–922. doi:10.1056/NEJM199504063321404
   PubMed Web of Science ®Google Scholar
• Galanello R, Piga A, Forni GL, et al. Phase II clinical evaluation of deferasirox, a once daily oral chelating agent, in pediatric patients with B-thalassemia major. Hematol J. 2006;91:1343–1351.
   Google Scholar
• Adams P, Barton J. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. J Hepatol. 2011;55(2):453–458. doi:10.1016/j.jhep.2011.02.010
   PubMed Web of Science ®Google Scholar
• Al-Refaie FN, Silva CE, Wonke B. Hoffbrand AV changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload. J Clin Pathol. 1996;48(2):110–114. doi:10.1136/jcp.48.2.110
   Web of Science ®Google Scholar
• Sinakos E, Vasilios P, Efthimia V, Ioanna T, Maria RG. Is liver stiffness really unrelated to liver iron concentration? Br J Haematol. 2010;150(2):247–248. doi:10.1111/j.1365-2141.2010.08183.x
   PubMed Web of Science ®Google Scholar
• Ezzat H. Utility of transient elastography (FibroScan) in estimating hepatic iron concentration in comparison to MRI in patients with transfusion dependent hemoglobinopathies. [Abstract]. Blood. 2014;124(21):4888. doi:10.1182/blood.V124.21.4888.4888
   Web of Science ®Google Scholar
• Majd Z, Haghpanah S, Ajami G, et al. Serum ferritin levels correlation with heart and liver MRI and LIC in patients with transfusion-dependent thalassemia. Iran Red Crescent Med J. 2015;17(4):e24959. doi:10.5812/ircmj.17(4)2015.24959
   PubMed Web of Science ®Google Scholar
• Origa R, Barella S, Argiolas GM, Bina P, Agus A, Galanello R. No evidence of cardiac iron in 20 never or minimally transfused patients with thalassemia intermedia. Hematol J. 2008;93(7):1095–1096. doi:10.3324/haematol.12484
   Google Scholar
• Aessopos A, Kati M, Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. J Hematol. 2007;92(5):658–665. doi:10.3324/haematol.10915
   Web of Science ®Google Scholar
• Aessopos A, Farmakis D, Deftereos S, et al. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005;127(5):1523–1530. doi:10.1378/chest.127.5.1523
   PubMed Web of Science ®Google Scholar
• Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systematic review and meta-analysis. Hepatology. 2015;61(1):29. doi:10.1002/hep.27382
   Web of Science ®Google Scholar
• Lubis AM, Atmakusuma TD, Kurnawan J, Harimurti K. Korelasi antara muatan besi berlebih darah dan hati dengan nilai elastografi hati pada pasien thalasemia intermedia dewasa yang mendapatkan transfusi darah. [Correlation between blood and liver excess iron load and liver elastographic values in adult intermedia thalassemia patients receiving blood transfusions] [Thesis]; 2016. Indonesian.
   Google Scholar